Target intelligence / Profile preview

Cellular and lysosomal membranes

Molecular classification
Other
01

Overview

Cellular membranes, including the plasma membrane and the membranes of intracellular organelles such as lysosomes and neutrophil granules, are complex lipid bilayers that define cellular boundaries and compartmentalize biochemical processes. These membranes play a pivotal role in the immune response, particularly in neutrophils, where they sequester potent hydrolytic enzymes and antimicrobial peptides within granules to prevent self-digestion of the host cell (Nathan, 2006). In various inflammatory and autoimmune diseases, the unintended rupture or degranulation of these compartments leads to the release of these enzymes into the extracellular space, causing significant tissue damage (Weissmann, 1969). Pharmacological intervention often involves the use of membrane-stabilizing agents, such as glucocorticoids and lysosomotropic drugs like hydroxychloroquine, which increase the stability of these lipid bilayers and prevent the release of inflammatory mediators (Mauthe et al., 2018). By maintaining the integrity of lysosomal and granule membranes, these drugs mitigate the severity of the inflammatory cascade. However, because these membranes are fundamental to all cells, therapeutic targeting must be carefully managed to avoid systemic toxicity or the disruption of essential endocytic and autophagic pathways (StatPearls, 2023). Consequently, these structures are considered broad therapeutic targets in the management of conditions like rheumatoid arthritis and systemic lupus erythematosus.

Other names
Biological membranesPlasma membraneLysosomal membraneNeutrophil granule membraneCytoplasmic membraneGranule membrane
02

Mechanism of action

Stabilization of lipid bilayers to prevent the release of cytotoxic enzymes and inflammatory mediators from intracellular compartments.

03

Biological functions

Cellular compartmentalizationImmune responseExocytosisPhagocytosisApoptosis
04

Disease associations

InflammationAutoimmune diseaseInfectionCancer
05

Safety considerations

Systemic toxicityImpaired host defenseDisruption of autophagyLysosomal storage interferenceInhibition of phagosome-lysosome fusion
06

Interacting drugs

Dexamethasone

6 more in the full profile.

07

Biomarkers

MyeloperoxidaseLysosomal-associated membrane protein 1Beta-glucuronidaseLactoferrin

Beyond the preview

Go deeper on Cellular and lysosomal membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular and lysosomal membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call